WallStreetZenWallStreetZen

NASDAQ: NAUT
Nautilus Biotechnology Inc Stock Forecast, Predictions & Price Target

Analyst price target for NAUT

Based on 2 analysts offering 12 month price targets for Nautilus Biotechnology Inc.
Min Forecast
$3.00+18.58%
Avg Forecast
$4.50+77.87%
Max Forecast
$6.00+137.15%

Should I buy or sell NAUT stock?

Based on 2 analysts offering ratings for Nautilus Biotechnology Inc.
Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NAUT stock forecasts and price targets.

NAUT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-06-27
lockedlocked$00.00+00.00%2024-06-03

1 of 1

Forecast return on equity

Is NAUT forecast to generate an efficient return?
Company
N/A
Industry
73.55%
Market
80.54%

Forecast return on assets

Is NAUT forecast to generate an efficient return on assets?
Company
N/A
Industry
31.45%

NAUT earnings per share forecast

What is NAUT's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$0.68
Avg 2 year Forecast
-$0.80
Avg 3 year Forecast
-$0.38

NAUT revenue forecast

What is NAUT's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$3.8M
Avg 2 year Forecast
$3.8M
Avg 3 year Forecast
$27.3M

NAUT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NAUT$2.53$4.50+77.87%Buy
ADCT$3.82$9.00+135.60%Strong Buy
BDTX$5.65$13.00+130.09%Strong Buy
RNAC$17.74$43.83+147.09%Strong Buy
INZY$5.15$16.00+210.68%Strong Buy

Nautilus Biotechnology Stock Forecast FAQ

Is Nautilus Biotechnology Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: NAUT) stock is to Buy NAUT stock.

Out of 2 analysts, 1 (50%) are recommending NAUT as a Strong Buy, 0 (0%) are recommending NAUT as a Buy, 1 (50%) are recommending NAUT as a Hold, 0 (0%) are recommending NAUT as a Sell, and 0 (0%) are recommending NAUT as a Strong Sell.

If you're new to stock investing, here's how to buy Nautilus Biotechnology stock.

What is NAUT's earnings growth forecast for 2024-2026?

(NASDAQ: NAUT) Nautilus Biotechnology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.45%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.02%.

Nautilus Biotechnology's earnings in 2024 is -$67,440,000.On average, 2 Wall Street analysts forecast NAUT's earnings for 2024 to be -$84,553,885, with the lowest NAUT earnings forecast at -$85,180,210, and the highest NAUT earnings forecast at -$83,927,560. On average, 2 Wall Street analysts forecast NAUT's earnings for 2025 to be -$100,212,012, with the lowest NAUT earnings forecast at -$101,464,662, and the highest NAUT earnings forecast at -$98,959,362.

In 2026, NAUT is forecast to generate -$47,600,706 in earnings, with the lowest earnings forecast at -$47,600,706 and the highest earnings forecast at -$47,600,706.

What is NAUT's revenue growth forecast for 2024-2026?

(NASDAQ: NAUT) Nautilus Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.19%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.57%.

Nautilus Biotechnology's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast NAUT's revenue for 2024 to be $473,376,492, with the lowest NAUT revenue forecast at $473,376,492, and the highest NAUT revenue forecast at $473,376,492. On average, 1 Wall Street analysts forecast NAUT's revenue for 2025 to be $473,376,492, with the lowest NAUT revenue forecast at $473,376,492, and the highest NAUT revenue forecast at $473,376,492.

In 2026, NAUT is forecast to generate $3,413,596,924 in revenue, with the lowest revenue forecast at $3,413,596,924 and the highest revenue forecast at $3,413,596,924.

What is NAUT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: NAUT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 31.45%.

What is NAUT's Price Target?

According to 2 Wall Street analysts that have issued a 1 year NAUT price target, the average NAUT price target is $4.50, with the highest NAUT stock price forecast at $6.00 and the lowest NAUT stock price forecast at $3.00.

On average, Wall Street analysts predict that Nautilus Biotechnology's share price could reach $4.50 by Jun 27, 2025. The average Nautilus Biotechnology stock price prediction forecasts a potential upside of 77.87% from the current NAUT share price of $2.53.

What is NAUT's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: NAUT) Nautilus Biotechnology's current Earnings Per Share (EPS) is -$0.55. On average, analysts forecast that NAUT's EPS will be -$0.68 for 2024, with the lowest EPS forecast at -$0.68, and the highest EPS forecast at -$0.67. On average, analysts forecast that NAUT's EPS will be -$0.80 for 2025, with the lowest EPS forecast at -$0.81, and the highest EPS forecast at -$0.79. In 2026, NAUT's EPS is forecast to hit -$0.38 (min: -$0.38, max: -$0.38).

What is NAUT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: NAUT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.